These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30715289)

  • 21. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Suto S; Zagar Z
    Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Replacement of third-generation cephalosporins by piperacillin-tazobactam decreases colonization of extended-spectrum beta-lactamases-producing intestinal Escherichia coli].
    Zhao ZM; Chu YZ; Wan JH; Bai YL; Zhang JP; Li JB; Wang X; Wang Q; Li LY; Chen BY
    Zhonghua Nei Ke Za Zhi; 2007 Sep; 46(9):714-7. PubMed ID: 18028795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of end-only-functionalized oligo(arylene-ethynylene)s in killing bacterial biofilms.
    Dascier D; Ji E; Parthasarathy A; Schanze KS; Whitten DG
    Langmuir; 2012 Aug; 28(31):11286-90. PubMed ID: 22799576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.
    Zhang C; Xu X; Pu S; Huang S; Sun J; Yang S; Zhang L
    Infect Genet Evol; 2014 Oct; 27():271-6. PubMed ID: 25107431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of oxygen limitation in the resistance of agar-entrapped, sessile-like Escherichia coli to aminoglycoside and beta-lactam antibiotics.
    Tresse O; Jouenne T; Junter GA
    J Antimicrob Chemother; 1995 Sep; 36(3):521-6. PubMed ID: 8830016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osmotic Compounds Enhance Antibiotic Efficacy against Acinetobacter baumannii Biofilm Communities.
    Falghoush A; Beyenal H; Besser TE; Omsland A; Call DR
    Appl Environ Microbiol; 2017 Oct; 83(19):. PubMed ID: 28733283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial efficacy of tobramycin against anaerobic Escherichia coli cultures in the presence of electron acceptors.
    Tresse O; Jouenne T; Junter GA
    J Antimicrob Chemother; 1997 Sep; 40(3):419-21. PubMed ID: 9338496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High genetic diversity of extended-spectrum β-lactamases producing Escherichia coli in feces of horses.
    Sadikalay S; Reynaud Y; Guyomard-Rabenirina S; Falord M; Ducat C; Fabre L; Le Hello S; Talarmin A; Ferdinand S
    Vet Microbiol; 2018 Jun; 219():117-122. PubMed ID: 29778183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biofilm Antimicrobial Susceptibility Increases With Antimicrobial Exposure Time.
    Castaneda P; McLaren A; Tavaziva G; Overstreet D
    Clin Orthop Relat Res; 2016 Jul; 474(7):1659-64. PubMed ID: 26797908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Microfluidic Approach to Investigating a Synergistic Effect of Tobramycin and Sodium Dodecyl Sulfate on Pseudomonas aeruginosa Biofilms.
    Shin S; Ahmed I; Hwang J; Seo Y; Lee E; Choi J; Moon S; Hong JW
    Anal Sci; 2016; 32(1):67-73. PubMed ID: 26753708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and Characterization of Extended-Spectrum Beta-Lactamases-Producing Escherichia coli in Animals.
    Suay-García B; Galán F; Rodríguez-Iglesias MA; Pérez-Gracia MT
    Vector Borne Zoonotic Dis; 2019 Feb; 19(2):115-120. PubMed ID: 30129883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic and genotypic characterizations of Chinese strains of Escherichia coli producing extended-spectrum beta-lactamases.
    Shen D; Biedenbach DJ; Winokur PL; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jul; 34(3):159-64. PubMed ID: 10403094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China.
    Yu Y; Ji S; Chen Y; Zhou W; Wei Z; Li L; Ma Y
    J Infect; 2007 Jan; 54(1):53-7. PubMed ID: 16533535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
    Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan.
    Yagi T; Kurokawa H; Shibata N; Shibayama K; Arakawa Y
    FEMS Microbiol Lett; 2000 Mar; 184(1):53-6. PubMed ID: 10689165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.
    Tängdén T; Adler M; Cars O; Sandegren L; Löwdin E
    J Antimicrob Chemother; 2013 Jun; 68(6):1319-26. PubMed ID: 23478794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of extended-spectrum beta-lactamases and drug sensitivity test in clinical isolates of the family Enterobacteriaceae in Shanghai].
    Lin Q; Luo W; Xiu Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul; 23(7):420-2. PubMed ID: 11778509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of l-Arginine and l-Histidine on the structural, optical and antibacterial properties of Mg doped ZnO nanoparticles tested against extended-spectrum beta-lactamases (ESBLs) producing Escherichia coli.
    Haja Hameed AS; Louis G; Karthikeyan C; Thajuddin N; Ravi G
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Mar; 211():373-382. PubMed ID: 30593947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.